Abstract
East Asians have a large range of skin types and different cultural beliefs.Knowledge about normal variations in skin color and common pigmentary disorders among East Asians is essential to avoid overdiagnosis.Although most pigmentation disorders are benign or non specific, some pigmentation disorders present cosmetic or psychological challenges to the patient, necessitating systematic evaluation and treatment.Pigmentary disorders are broadly classified into three groups:
-
1.
Hypopigmentation or depigmentation
-
2.
Hyperpigmentation
-
3.
Mixed
These disorders can be further subcategorized based on their age of onset, pattern and distribution. i.e., Hypomelanosis of lto is categorized under early onset patterned hypopigmentary disorder.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Liu W, Lai W, Wang XM, Li L, Tian Y, Lu Y, Wu YY, Li Y, Zhang P, Wu Y, Chen L. Skin phototyping in a Chinese female population: analysis of four hundred and four cases from four major cities of China. Photodermatol Photoimmunol Photomed. 2006;22(4):184–8.
Holbrook KA, Underwood RA, Vogel AM, Gown AM, Kimball H. The appearance, density and distribution of melanocytes in human embryonic and fetal skin revealed by the anti-melanoma monoclonal antibody, HMB-45. Anat Embryol (Berl). 1989;180:443.
Selmanowitz VJ, Krivo JM. Pigmentary demarcation lines. Comparison of Negroes with Japanese. Br J Dermatol. 1975;93(4):371–7.
Xu AE, Huang B, Li YW, Wang P, Shen H. Clinical, histopathological and ultrastructural characteristics of naevus depigmentosus. Clin Exp Dermatol. 2008;33(4):400–5.
Lee HS, Chun YS, Hann SK. Nevus depigmentosus: clinical features and histopathologic characteristics in 67 patients. J Am Acad Dermatol. 1999;40(1):21–6.
Olsson MJ, Juhlin L. Leucoderma treated by transplantation of a basal cell layer enriched suspension. Br J Dermatol. 1998;138:644–8.
Glover MT, Brett EM, Atherton DJ. Hypomelanosis of Ito: spectrum of the disease. J Pediatr. 1989;115(1):75–80.
Pascual-Castroviejo I. Hypomelanosis of Ito. Neurologia. 1997;12:300–5.
Ruiz-Maldonado R, Toussaint S, Tamayo L, Laterza A, Del Castillo V. Hypomelanosis of lto: diagnostic criteria and report of 41 cases. Pediatr Dermatol. 1992;9:1–10.
Fleury P, de Groot WP, Delleman JW, et al. Tuberous sclerosis: the incidence of sporadic cases versus familial cases. Brain Dev. 1980;2:107–17.
Roach ES, Delgado MR. Tubereous sclerosis. Dermatol Clin. 1995;13:151–61.
Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann N Y Acad Sci. 1991;615:125–7.
Hong CH, Darling TN, Lee CH. Prevalence of tuberous sclerosis complex in Taiwan: a national population-based study. Neuroepidemiology. 2009;33:335–41.
Jóźwiak S, Goodman M, Lamm SH. Poor mental development in patients with tuberous sclerosis complex: clinical risk factors. Arch Neurol. 1998;55:379–84.
Kim SK, Kang HY, Lee ES, Kim YC. Clinical and histopathologic characteristics of nevus depigmentosus. J Am Acad Dermatol. 2006;55:423–8.
Webb DW, Clarke A, Fryer A, Osborne JP. The cutaneous features of tuberous sclerosis: a population study. Br J Dermatol. 1996;135:1–5.
Salido R, Garnacho-Saucedo G, Cuevas-Asencio I, Ruano J, Galan-Gutierrez M, Velez A, et al. Sustained clinical effectiveness and favourable safety profile of topical Sirolimus for tuberous sclerosis associated facial angiofibroma. J Eur Acad Dermatol Venereol. 2012;26(10):1315–8.
Giebel LB, Spritz RA. Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism. Proc Natl Acad Sci U S A. 1991;88:8696–9.
Cooke JV. Familial white skin spotting (piebaldness) with white forelock. J Pediatr. 1952;41:1–12.
Chang T, McGrae JD, Hashimoto K. Ultrastructural study of two patients with both Piebaldism and Neurofibromatosis type 1. Pediatr Dermatol. 1993;10:224–34.
Tay YK. Neurofibromatosis type 1 and Piebaldism: a case report. Dermatology. 1998;197:401–2.
Shah KN, Dalal SJ, Desai MP, et al. White forelock, pigmentary disorder of the irides, and long segment Hirschsprung disease; possible variant of Waardenburg syndrome. J Pediatr. 1981;99:432–5.
Inagaki K, Suzuki T, Shimizu H, Ishii N, Umezawa Y. Oculocutaneous albinism type 4 is one of the most common types of albinism in Japan. Am J Hum Genet. 2004;74(3):466–71.
Liza AF, Aziah AM. Albinism and lung fibrosis in a young man – the first case of adult Hermansky-Pudlak Syndrome reported in Malaysia. Med J Malaysia. 2012;67(6):620–1.
King RA, Summer CG. Albinism. Dermatol Clin. 1988;6:217–27.
Ramsay M, Colman MA, Steven G, et al. The tyrosine positive oculocutaneous albinism locus maps to chromosome 15q11.2-q12. Am J Hum Genet. 1992;51:879–84.
Toyofuku K, Valencia JC, Kushimoto T, et al. The etiology of oculocutaneous albinism (OCA) type 2: the pink protein modulates the processing and transport of tyrosinase. Pigment Cell Res. 2002;15:217–24.
Boissy RE, Zhao H, Oetting WS, et al. Mutation in and lack of expression of Tyrosinase related protein 1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: new subtype of albinism classified as “OCA3”. Am J Hum Genet. 1996;58:1145–56.
Kobayashi T, Urabe K, Winder A, et al. Tyrosinase related protein-1 (TRP-1) functions as a DHICA oxidase in melanin biosynthesis. EMBO J. 1994;13:5818–25.
Newton JM, Cohen-Barak O, Hagiwara N, et al. Mutation in human orthologue of the mouse underwhite gene (UW) underlie a new form of oculocutaneous albinism, OCA4. Am J Hum Genet. 2001;68:981–8.
Menasche G, Fischer A, de Saint Basile G. Griscelli syndrome type 1 and 2. Am J Hum Genet. 2002;71:1237–8.
Menasche G, Pastural E, Feldmann J, et al. Mutations in RAB27A cause Griscelli syndrome associated with hemophagocytic Syndrome. Nat Genet. 2000;25:173–6.
Menasche G, Ho CH, Sanal O, et al. Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion ( GS1). J Clin Invest. 2003;112:450–6.
Vinton NE, Dahlstrom KA, Strobel CT, Ament ME. Macrocytosis and pseudoalbinism: manifestations of selenium deficiency. J Pediatr. 1987;111:711–7.
Durán-McKinster C, Rodríguez-Jurado R, Ridaura C, Orozco-Covarrubias ML, Tamayo-Sánchez L, Ruiz-Maldonado R. Elejade syndrome: a melanolysosomal neurocutaneous syndrome: clinical and morphological findings in 7 patients. Arch Dermatol. 1999;135:182–6.
Peterson J, Drolet BA, Esterly NB. Menkes’ Kinky-hair syndrome. Pediatr Dermatol. 1998;15:137–9.
Fox H. Partial depigmentation: chiefly on the face in Negro children. Arch Dermatol Syphilol. 1923;7:268–9.
Tay YK, Kong KH, Khoo L, Goh CL, Giam YC. The prevalence and descriptive epidemiology of atopic eczema in Singapore school children. Br J Dermatol. 2002;146:101–6.
Rigopoulos D, Gregoriou S, Charissi C, et al. Tacrolimus ointment 0.1% in pityriasis alba: an open label, randomised controlled study. Br J Dermatol. 2006;155:152–5.
Fujita WH, McCormick CL, Parneix-Spake A. An exploratory study to evaluate the efficacy of pimecrolimus cream 1% for the treatment of pityriasis alba. Int J Dermatol. 2007;46:700–5.
Crespo Erchiga V, Delgado Florencio V. Malassezia species in skin diseases. Curr Opin Infect Dis. 2002;15:133–42.
Ryan EA, Sanderson KV, Bartak P, Samman PD. Can mycosis fungoides begin in the epidermis? A hypothesis. Br J Dermatol. 1973;88:419–29.
Clayton R, Warin A. Pityriasis lichenoides chronica presenting as hypopigmentation. Br J Dermatol. 1979;100(3):297–302.
Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, Robson A, Calonje E, Stefanato CM, Wain EM, Wilkins B, Fields PA, Dean A, Webb K, Scarisbrick J, Morris S, Whittaker SJ. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal by Nita Sally Agar et al. J Clin Oncol. 2010;28:4730–9.
Ezzedine K, Diallo A, Léauté-Labrèze C, Mossalayi D, Gauthier Y, Bouchtnei S, Cario-André M, Seneschal J, Boralevi F, Jouary T, Taieb A. Multivariate analysis of factors associated with early-onset segmental and nonsegmental vitiligo: a prospective observational study of 213 patients. Br J Dermatol. 2011;165(1):44–9.
Chun WH, Hann S-H. The progression of nonsegmental vitiligo: clinical analysis of 318 patients. Int J Dermatol. 1997;36:908–10.
Lepe V, Moncada B, Castanedo-Cazares JP, et al. Double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for treatment of childhood vitiligo. Arch Dermatol. 2003;139:581–5.
Weismann K, Lorentzen HF. Dermoscopic color perspective. Arch Dermatol. 2006;142:1250.
Landau M, Krafchik B. The diagnostic value of café au lait spot. J Am Acad Dermatol. 1999;40:877–90.
Hogeling M, Frieden IJ. Segmental pigmentation disorder. Br J Dermatol. 2010;162:1337–41.
Jacob A. Birthmarks. Pediatr Ann. 1976;5:743–58.
Crowe FW, Schull WJ. Diagnostic importance of cafe au lait spots in neurofibromatosis. Arch Intern Med. 1993;91:758–66.
Cordova A. The Mongolian spot: a study of ethnic differences and literature review. Clin Pediatr. 1981;20:714–9.
Jacobs A. The incidence of birthmarks in the neonate. Pediatrics. 1976;58:218–22.
Hanson M, Lupski JR, Hicks J, et al. Association of dermal melanocytosis with lysosomal storage disease: clinical features and hypotheses regarding pathogenesis. Arch Dermatol. 2003;139:916–20.
Mehta V, Vasanth V, Balachandran C, Mathew M. Linear and whorled nevoid hypermelanosis. Int J Dermatol. 2011;50(4):491–2.
Metta AK, Ramachandra S, Sadath N, Manupati S. Linear and whorled nevoid hypermelanosis in three successive generations. Indian J Dermatol Venereol Leprol. 2011;77(3):403.
Di Lernia V. Linear and whorled hypermelanosis. Pediatr Dermatol. 2007;24:205–10.
Hassab-El-Naby HMM, Alsaleh QA, Fathallah MA. Linear and whorled hypermelanosis: report of a case associated with cerebral palsy. Pediatr Dermatol. 1996;13:148–50.
Schepis C, Siragusa M, Alberti A, et al. Linear and whorled nevoid hypermelanosis in a boy with mental retardation and congenital defects. Int J Dermatol. 1996;35:654–5.
Verghese S, Newlin A, Miller M, et al. Mosaic trisomy 7 in a patient with pigmentary abnormalities. Am J Med Genet. 1999;87:371–4.
Alrobaee AA, Alsaif F. Linear and whorled nevoid hypermelanosis associated with developmental delay and generalized convulsions. Int J Dermatol. 2004;43:145–7.
Ment L, Alper J, Sirota RL, et al. Infant with abnormal pigmentation, malformation and immune deficiency. Arch Dermatol. 1978;114:1043–4.
Hartmann A, Hofmann UB, Hoehn H, et al. Postnatal confirmation of prenatally diagnosed trisomy 20 mosaicism in a patient with linear and whorled nevoid hypermelanosis. Pediatr Dermatol. 2004;2:636–41.
Legius E, Schrander-Stumpel C, Schollen E, et al. PTPN 11(SH 2) mutations in LEOPARD syndrome. J Med Genet. 2002;39:571–4.
Gorlin RJ, Anderson RC, Moller JH. The Leopard syndrome revisited. Birth Defects Orig Artic Ser. 1971;7:110–5.
Arnsmeier SL, Paller AS. Pigmentary anomalies in multiple lentigines syndrome: is it distinct from LEOPARD syndrome? Pediatr Dermatol. 1996;13:100–4.
Nordlund JJ, Lerner AB, Braveman IM, et al. The multiple lentigines syndrome. Arch Dermatol. 1973;107:259–61.
Marceshi L, Naldi L, Di Landro A, et al. Segmental lentiginosis with “lentigo” histologic pattern. Am J Dermatopathol. 1992;14:323–7.
Carney JA, Gordon H, Carpenter PC, et al. The complex of myxomas, spotty pigmentation and endocrine over reactivity. Medicines (Baltimore). 1985;64:270–83.
Odeibat H. Transient neonatal pustular melanosis: a retrospective review. Middle East J Intern Med. 2013;6(5):44.
Robbins JH. Xeroderma pigmentosum. Defective DNA repair causes skin cancer and neurodegeneration. JAMA. 1988;260:384–8.
Fernandez FM, Martinez Soto MI, Fernandez Lorenzo JR, et al. Peutz Jegher syndrome in a neonate. J Pediatr. 1995;126:965–7.
DeDavid M, Orlow SJ, Provost N, Marghoob AA, Rao BK, Wasti Q, Huang CL, Kopf AW, Bart RS. Neurocutaneous melanosis: clinical features of large congenital melanocytic nevi in patients with manifest central nervous system melanosis. J Am Acad Dermatol. 1996;35(4):529–38.
Caplan RM. The natural course of urticaria pigmentosa. Analysis and follow up of 112 cases. Arch Dermatol. 1963;87:146–57.
Ramirez CO. Los cenicientos: Problema Clinica. Memoria del Primer Congreso Centroamericano de Dermatologia. 1957; p. 122–30.
Silverberg NB, Herz J, Wagner A, Paller AS. Erythema dyschromicum perstans in prepubertal children. Pediatr Dermatol. 2003;20(5):398–403.
Piquero-Martín J, Pérez-Alfonzo R, Abrusci V, Briceño L, Gross A, Mosca W, Tapia F, Convit J. Clinical trial with clofazimine for treating erythema dyschromicum perstans. Evaluation of cell-mediated immunity. Int J Dermatol. 1989;28(3):198–200.
Gönül M, Kiliç A, Cakmak SK, Gül U, Ekiz OD, Ergül G. Juvenile generalized acanthosis nigricans without any systemic disease. Pediatr Int. 2009;51:595–7.
Gao M, Wang PG, Yang S, et al. Two frameshift mutations in the RNA-specific adenosine deaminase gene associated with dyschromatosis symmetrica hereditaria. Arch Dermatol. 2005;141:193–6.
Urabe K, Hori Y. Dyschromatosis. Semin Cutan Med Surg. 1997;16:81–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Leong, K.F. (2015). Pigmentary Development of East Asian Skin. In: Silverberg, N., Durán-McKinster, C., Tay, YK. (eds) Pediatric Skin of Color. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6654-3_3
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6654-3_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6653-6
Online ISBN: 978-1-4614-6654-3
eBook Packages: MedicineMedicine (R0)